| Antibody–drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes M Abdollahpour‐Alitappeh, M Lotfinia, T Gharibi, J Mardaneh, ... Journal of cellular physiology 234 (5), 5628-5642, 2019 | 199 | 2019 |
| Potential drugs used in the antibody–drug conjugate (ADC) architecture for cancer therapy S Yaghoubi, MH Karimi, M Lotfinia, T Gharibi, M Mahi‐Birjand, E Kavi, ... Journal of cellular physiology 235 (1), 31-64, 2020 | 128 | 2020 |
| Targeting STAT3 in cancer and autoimmune diseases T Gharibi, Z Babaloo, A Hosseini, M Abdollahpour-Alitappeh, V Hashemi, ... European journal of pharmacology 878, 173107, 2020 | 80 | 2020 |
| Regulatory T and T helper 17 cells: Their roles in preeclampsia A Hosseini, S Dolati, V Hashemi, M Abdollahpour‐Alitappeh, M Yousefi Journal of cellular physiology 233 (9), 6561-6573, 2018 | 80 | 2018 |
| The role of microRNAs regulating the expression of matrix metalloproteinases (MMPs) in breast cancer development, progression, and metastasis M Javadian, T Gharibi, N Shekari, M Abdollahpour‐Alitappeh, ... Journal of Cellular Physiology 234 (5), 5399-5412, 2019 | 56 | 2019 |
| Exosomes and cancer: from molecular mechanisms to clinical applications A Jafari, A Babajani, M Abdollahpour-Alitappeh, N Ahmadi, ... Medical Oncology 38 (4), 45, 2021 | 53 | 2021 |
| Protective effects of pharmacological agents against aminoglycoside-induced nephrotoxicity: A systematic review M Mahi-Birjand, S Yaghoubi, M Abdollahpour-Alitappeh, Z Keshtkaran, ... Expert Opinion on Drug Safety 19 (2), 167-186, 2020 | 53 | 2020 |
| Study of antagonistic effects of Lactobacillus strains as probiotics on multi drug resistant (MDR) bacteria isolated from urinary tract infections (UTIs) A Naderi, R Kasra-Kermanshahi, S Gharavi, AAI Fooladi, MA Alitappeh, ... Iranian journal of basic medical sciences 17 (3), 201, 2014 | 47 | 2014 |
| Chimeric antigen receptor based therapy as a potential approach in autoimmune diseases: how close are we to the treatment? M Sadeqi Nezhad, A Seifalian, N Bagheri, S Yaghoubi, MH Karimi, ... Frontiers in immunology 11, 603237, 2020 | 46 | 2020 |
| Nickel-Doped Cerium Oxide Nanoparticles: Green Synthesis Using Stevia and Protective Effect against Harmful Ultraviolet Rays M Khatami, M Sarani, F Mosazadeh, M Rajabalipour, A Izadi, ... Molecules 24 (24), 4424, 2019 | 44 | 2019 |
| Biomedical applications of yeast-a patent view, part one: yeasts as workhorses for the production of therapeutics and vaccines F Roohvand, M Shokri, M Abdollahpour-Alitappeh, P Ehsani Expert opinion on therapeutic patents 27 (8), 929-951, 2017 | 43 | 2017 |
| IL-21 and IL-21-producing T cells are involved in multiple sclerosis severity and progression T Gharibi, A Hosseini, F Marofi, M Oraei, S Jahandideh, ... Immunology letters 216, 12-20, 2019 | 37 | 2019 |
| How hypoxia regulate exosomes in ischemic diseases and cancer microenvironment? S Yaghoubi, H Najminejad, M Dabaghian, MH Karimi, ... IUBMB life 72 (7), 1286-1305, 2020 | 34 | 2020 |
| Current advances and challenges in COVID-19 vaccine development: from conventional vaccines to next-generation vaccine platforms A Jafari, F Danesh Pouya, Z Niknam, M Abdollahpour‑Alitappeh, ... Molecular biology reports 49 (6), 4943-4957, 2022 | 33 | 2022 |
| Emerging roles of exosomal miRNAs in breast cancer drug resistance H Najminejad, SM Kalantar, M Abdollahpour‐Alitappeh, MH Karimi, ... IUBMB life 71 (11), 1672-1684, 2019 | 33 | 2019 |
| Growth-inhibitory and apoptosis-inducing effects of Punica granatum L. var. spinosa (Apple Punice) on fibrosarcoma cell lines KS Sepehr, B Baradaran, M Mazandarani, B Yousefi, MA Alitappeh, ... Advanced pharmaceutical bulletin 4 (Suppl 2), 583, 2014 | 33 | 2014 |
| Trastuzumab‐monomethyl auristatin E conjugate exhibits potent cytotoxic activity in vitro against HER2‐positive human breast cancer M Abdollahpour‐Alitappeh, M Lotfinia, N Bagheri, K Sineh Sepehr, ... Journal of Cellular Physiology 234 (3), 2693-2704, 2019 | 32 | 2019 |
| Adeno-associated virus as a gene therapy vector: strategies to neutralize the neutralizing antibodies M Lotfinia, M Abdollahpour-Alitappeh, B Hatami, MR Zali, M Karimipoor Clinical and Experimental Medicine 19, 289-298, 2019 | 30 | 2019 |
| A developed antibody–drug conjugate rituximab-vcMMAE shows a potent cytotoxic activity against CD20-positive cell line M Abdollahpour-Alitappeh, SM Hashemi Karouei, M Lotfinia, ... Artificial cells, nanomedicine, and biotechnology 46 (sup2), 1-8, 2018 | 28 | 2018 |
| Induced pluripotent stem cells (iPSCs) provide a potentially unlimited T cell source for CAR-T cell development and off-the-shelf products M Sadeqi Nezhad, M Abdollahpour-Alitappeh, B Rezaei, M Yazdanifar, ... Pharmaceutical Research 38 (6), 931-945, 2021 | 26 | 2021 |
Nader BagheriShahrekord University of Medical SciencesVerified email at skums.ac.ir
